Skybiotech Healthcare Ltd
Skybiotech Healthcare Board to Meet for Q2 FY27 Un-Audited Financial Results
RESULTS
● No Immediate Change
LOW RISK
📅 Filed on BSE: 05 Nov 2026, 02:04 PM IST · BSE ID: f8a56899-eae8-4a76-b52e-e7e3c71ea2c2
View Original BSE Filing (PDF)
💡
In Simple Terms
Skybiotech Healthcare's board will meet on November 10, 2026, to review its latest financial results.
🤖 AI Summary
- Skybiotech Healthcare Ltd board meeting set for Tuesday, November 10, 2026.
- The board will consider and approve un-audited financial results for Q2 FY27.
- Results cover the quarter and half year ended September 30, 2026.
- Intimation provided under Regulation 29(1)(a) of SEBI (LODR) Regulations, 2015.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders based on this intimation.
👤
Who Is Affected
All shareholders are indirectly affected as the upcoming financial results will provide an update on the company's performance.
🔍
Management Signal
The scheduled board meeting indicates management is proceeding with regular financial reporting for Q2 FY27 as per regulatory requirements.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List - track these upcoming events
Board meeting outcome on November 10, 2026 — for Q2 FY27 financial results.
Release of Q2 FY27 un-audited financial results — for performance data.
Any further board decisions taken with the chair's permission.
LOW RISK
This filing is a routine board meeting intimation, not a disclosure of new risks.
💡 Investor Takeaway
Skybiotech Healthcare Ltd has scheduled a Board Meeting for November 10, 2026, to consider and approve its un-audited financial results and limited review report for the quarter and half-year ended September 30, 2026 (Q2 FY27). No financial data is disclosed in this intimation.
📅 Company Track Record
A previous filing on May 26, 2026, also intimated a board meeting to approve audited financial results for FY26. This current filing is for Q2 FY27 un-audited results, maintaining a consistent pattern of timely financial reporting intimations.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
When is Skybiotech Healthcare's next board meeting scheduled?
Skybiotech Healthcare Ltd has scheduled its next Board Meeting for Tuesday, November 10, 2026.
What financial results will be considered at the November 2026 board meeting?
The board will consider and approve the un-audited financial results for the quarter and half year ended September 30, 2026 (Q2 FY27).
What regulatory requirement is this board meeting intimation under?
This intimation is made in terms of Regulation 29(1)(a) of the SEBI (LODR) Regulations, 2015.
Questions based on this BSE filing only. For information purposes.